Edwards  	Edwards  	 NNP	B-NP
CENTERA  	CENTERA  	 NNP	I-NP
valve  	valve  	 FW	I-NP
Transcatheter  	Transcatheter  	 FW	I-NP
aortic  	aortic  	 FW	I-NP
valve  	valve  	 FW	I-NP
implantation  	implantation  	 FW	I-NP
( 	( 	 -LRB-	O
TAVI 	TAVI 	 NNP	B-NP
)  	)  	 -RRB-	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
adopted  	adopted  	 VBN	O
worldwide  	worldwide  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
prominent  	prominent  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
alternative  	alternative  	 NN	I-NP
for  	for  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
high-risk  	high-risk  	 JJ	B-NP
severe  	severe  	 JJ	O
symptomatic  	symptomatic  	 JJ	B-NP
aortic  	aortic  	 JJ	I-NP
stenosis 	stenosis 	 NN	I-NP
.  	.  	 .	O
Despite  	Despite  	 IN	O
its  	its  	 PRP$	O
more  	more  	 JJR	O
widespread  	widespread  	 JJ	O
adoption  	adoption  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
treatment  	treatment  	 NN	B-NP
option  	option  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
increasing  	increasing  	 JJ	O
experience  	experience  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
centres 	centres 	 NN	O
,  	,  	 ,	O
TAVI  	TAVI  	 NNP	B-NP
is  	is  	 VBZ	O
still  	still  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
complications 	complications 	 NNS	B-NP
.  	.  	 .	O
Therefore 	Therefore 	 RB	O
,  	,  	 ,	O
improvements  	improvements  	 NNS	B-NP
in  	in  	 IN	O
transcatheter  	transcatheter  	 JJ	B-NP
heart  	heart  	 NN	I-NP
valve  	valve  	 NNS	I-NP
( 	( 	 -LRB-	O
THV 	THV 	 NNP	B-NP
)  	)  	 -RRB-	O
technology 	technology 	 NN	O
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
optimisation  	optimisation  	 NN	B-NP
of  	of  	 IN	I-NP
device  	device  	 NN	I-NP
function  	function  	 NN	I-NP
with  	with  	 IN	O
superior  	superior  	 JJ	O
deliverability 	deliverability 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
valve  	valve  	 JJ	B-NP
repositioning 	repositioning 	 NN	I-NP
,  	,  	 ,	O
are  	are  	 VBP	O
desirable 	desirable 	 JJ	O
.  	.  	 .	O
Accordingly 	Accordingly 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
article  	article  	 NN	O
describes  	describes  	 VBZ	O
the  	the  	 DT	O
new  	new  	 JJ	O
self-expandable  	self-expandable  	 JJ	B-NP
Edwards  	Edwards  	 NNP	I-NP
CENTERA  	CENTERA  	 NNP	I-NP
THV 	THV 	 NNP	I-NP
,  	,  	 ,	O
made  	made  	 VBN	O
of  	of  	 IN	O
nitinol  	nitinol  	 NN	B-NP
and  	and  	 CC	O
treated  	treated  	 VBN	O
bovine  	bovine  	 JJ	B-NP
pericardial  	pericardial  	 JJ	I-NP
tissue 	tissue 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
delivered  	delivered  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
motorised  	motorised  	 JJ	B-NP
low-profile  	low-profile  	 JJ	I-NP
delivery  	delivery  	 NN	I-NP
system  	system  	 NN	I-NP
which  	which  	 WDT	O
potentially  	potentially  	 RB	O
permits  	permits  	 VBZ	O
accurate  	accurate  	 JJ	O
valve  	valve  	 JJ	B-NP
placement  	placement  	 NN	I-NP
and  	and  	 CC	O
valve  	valve  	 JJ	B-NP
repositioning  	repositioning  	 NN	I-NP
by  	by  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
operator 	operator 	 NN	O
.  	.  	 .	O
First-in-human  	First-in-human  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
experience  	experience  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
CENTERA  	CENTERA  	 NNP	B-NP
THV  	THV  	 NNP	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
promising  	promising  	 JJ	O
but  	but  	 CC	O
larger  	larger  	 JJR	O
series  	series  	 NN	O
with  	with  	 IN	O
longer  	longer  	 JJR	O
follow-up  	follow-up  	 NNS	O
are  	are  	 VBP	O
warranted  	warranted  	 VBN	O
to  	to  	 TO	O
confirm  	confirm  	 VB	O
these  	these  	 DT	O
initial  	initial  	 JJ	O
positive  	positive  	 JJ	B-NP
results 	results 	 NNS	I-NP
.  	.  	 .	O
